{"id":"glucosaminylmuramyl-dipeptide","rwe":[{"pmid":"36672691","year":"2023","title":"Inflammation Regulation by Bacterial Molecular Patterns.","finding":"","journal":"Biomedicines","studyType":"Clinical Study"},{"pmid":"35207480","year":"2022","title":"Dual Effect of Low-Molecular-Weight Bioregulators of Bacterial Origin in Experimental Model of Asthma.","finding":"","journal":"Life (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"33720635","year":"2021","title":"[BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].","finding":"","journal":"Terapevticheskii arkhiv","studyType":"Clinical Study"},{"pmid":"33720594","year":"2020","title":"[BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].","finding":"","journal":"Terapevticheskii arkhiv","studyType":"Clinical Study"},{"pmid":"32598599","year":"2019","title":"[Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide].","finding":"","journal":"Terapevticheskii arkhiv","studyType":"Clinical Study"}],"tags":[{"label":"glucosaminylmuramyl dipeptide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"licopid","offLabel":[],"synonyms":["glycopin","glucosaminylmuramyl dipeptide","licopid"],"timeline":[],"approvals":[],"brandName":"Licopid","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"glucosaminylmuramyl dipeptide","explanation":"Imagine your immune system as a security system that can sometimes get overactive and attack healthy cells. Licopid is thought to help calm down this system by interacting with a specific part of it, reducing inflammation and preventing damage to healthy tissues.","oneSentence":"Licopid works by interacting with a specific target in the body to produce a therapeutic effect.","technicalDetail":"Glucosaminylmuramyl dipeptide compounds like Licopid are thought to interact with pattern recognition receptors on immune cells, triggering a response that helps to regulate the immune system and prevent excessive inflammation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1322","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=glucosaminylmuramyl dipeptide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:46:15.694297","biosimilars":[],"competitors":[],"genericName":"glucosaminylmuramyl dipeptide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"CHEBI":"CHEBI:135873","UMLSCUI":"C0082715","PUBCHEM_CID":"118984439"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":28,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"recentPublications":[{"date":"2023 Jan 11","pmid":"36672691","title":"Inflammation Regulation by Bacterial Molecular Patterns.","journal":"Biomedicines"},{"date":"2022 Jan 27","pmid":"35207480","title":"Dual Effect of Low-Molecular-Weight Bioregulators of Bacterial Origin in Experimental Model of Asthma.","journal":"Life (Basel, Switzerland)"},{"date":"2021 Jan 10","pmid":"33720635","title":"[BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].","journal":"Terapevticheskii arkhiv"},{"date":"2020 Dec 15","pmid":"33720594","title":"[BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].","journal":"Terapevticheskii arkhiv"},{"date":"2019 Dec 15","pmid":"32598599","title":"[Muramyldipeptide - based compounds in current medicine: focus on glucosaminylmuramyl dipeptide].","journal":"Terapevticheskii arkhiv"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Licopid is a small molecule. Its modality is classified as a small molecule according to ChEMBL.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}